PROGRESSION-FREE SURVIVAL, PFS

Clinical trials for PROGRESSION-FREE SURVIVAL, PFS explained in plain language.

Never miss a new study

Get alerted when new PROGRESSION-FREE SURVIVAL, PFS trials appear

Sign up with your email to follow new studies for PROGRESSION-FREE SURVIVAL, PFS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Three-Pronged attack on aggressive lung cancer in seniors

Disease control Ongoing

This study is testing a new combination of three drugs—etoposide, anlotinib, and envafolimab—as a first treatment for older adults (65+) with extensive small cell lung cancer. The main goal is to see if this combo is safe and can help control the cancer and delay its progression.…

Matched conditions: PROGRESSION-FREE SURVIVAL, PFS

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Mar 23, 2026 15:16 UTC

PROGRESSION-FREE SURVIVAL, PFS

Get alerted when new PROGRESSION-FREE SURVIVAL, PFS trials appear

Three-Pronged attack on aggressive lung cancer in seniors